<DOC>
	<DOCNO>NCT00768521</DOCNO>
	<brief_summary>This study design alternative urodynamic platform well evaluate treatment effect medication overactive bladder . Part II dependent result Part I may conduct .</brief_summary>
	<brief_title>A Study Test Effects Tolterodine Tartrate Patients With Overactive Bladder ( 0000-107 )</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Patient postmenopausal female 40 75 year age Patient Body Mass Index ( BMI ) less equal 35 kg/m2 Patient document history overactive bladder least 6 month prior screen Patient stress mixed incontinence Patient history interstitial cystitis , painful bladder syndrome , chronic pelvic pain Patient history stroke , seizure , major neurological disorder Patient history fecal incontinence Patient history continual urine leakage Patient surgery correct stress urinary incontinence pelvic organ prolapse within 6 month study start Patient receive bladder train electrostimulation within 2 week study start Patient require catheter Patient take medication stop duration trial include certain anticholinergic smooth muscle relaxant Patient begin take tricyclic antidepressant , serotonin/norepinephrine reuptake inhibitor , calcium channel blocker , ephedrine/pseudoephedrine , diuretic therapy le 8 week study start Patient hormone replacement therapy le 12 week study start Patient must take medication arrhythmia Patient consume 2 alcoholic beverage per day Patient consume 3 serving caffeinated beverage per day ( 1 serve = 120 mg caffeine ) Patient multiple and/or severe allergy food drug Patient regularly use illegal drug</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>